influenza mRNA vaccine/COVID-19 mRNA vaccine (Moderna)

N/A

Report date: 2026/05/20 20:02:01

Base Information

Drug Nameinfluenza mRNA vaccine/COVID-19 mRNA vaccine (Moderna)
Drug Alias NameFlu + COVID vaccine (Moderna Therapeutics)mRNA-1083mRNA-1083.1mRNA-1083.2mRNA-1083.3
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine > mRNA vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Influenza, Human
Global Approved IndicationsCoronavirus Disease 2019 (COVID-19)
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEU
Original Approved Date2026/04/20
Country/TerritoryCanadaUnited StatesTaiwan +[6] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesModerna Inc
China Registration ClassN/A

Develop Information

Active CompaniesModerna IncModerna Biotech Spain SL
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)Influenza, Human
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A